HIV DNA vaccine (University of Oxford)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV DNA vaccine (University of Oxford)
Drug Alias NameMVA.HIVA vaccineHIV-1 gag polyepitope/Modified vaccinia virus Ankara vaccineHIVA.MVA vaccineModified vaccinia virus Ankara/HIV-1 gag polyepitope vaccineMVA vaccine +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of NairobiUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of OxfordUniversity Of NairobiNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A